News Posts
Gainsville, Florida -Autologous cord blood has received some recent media for its use in treatment of
cerebral palsy. Other groups have reported the use of allogeneic cord blood to have positive effects for conditions other than hematopoietic disorders, even in
absence of immune suppression. Accordingly...
Tuesday April 1st, 2008 @ 20:37:06 EST
Hyderabad, India -Mesenchymal stem cells are one of the most clinically advanced forms of stem cell therapy after hematopoietic stem cell transplantation. The conventional source for mesenchymal stem cells has been
bone marrow, however these cells can also be extracted from a variety of other tissues such as
teeth,
Sunday March 30th, 2008 @ 20:24:11 EST
SCOTTSDALE, AZ--(MARKET WIRE)--Mar 20, 2008 -- Medistem Laboratories, Inc. (OTC BB:MDSM.OB - News) is pleased to announce its recent co-authored article entitled, "Endometrial regenerative cells: a novel stem cell population" received BioMed Central's research article of the year in medicine award. The award recognizes excellence in research that has been made universally accessible...
Sunday March 23rd, 2008 @ 19:28:19 EST
The current accepted method of using cord blood is for post myeloablative hematopoietic reconstitution in patients with leukemias, or other hematological/metabolic disorders. Essentially the idea is that if you destroy the resident stem cells and administer "healthy" stem cells, then the progeny of the healthy stem cells will act in a dominant manner to reverse the disease.
Many clinicians...
Wednesday March 19th, 2008 @ 09:43:08 EST
Sydney, Australia -
The signals that control proliferation of hematopoietic stem cells are still relatively unknown. Not only is the study of the hematopoietic stem cell important because it is one of the most well characterized stem cell systems, but also it has some very strong practical implications in terms of treating disease. For example, hematopoietic toxicity is often the...
Wednesday March 12th, 2008 @ 02:38:49 EST
Nara Medical University, Japan -
Mesenchymal stem cells are classically defined as CD34 negative, CD45 negative, SH2 and SH4 positive, and Thy-1 (CD90) positive cells. Therapeutically mesenchymal stem cells are attractive because they do not require matching with recipients, supposedly because
mesenchymal stem cells are immune... Wednesday March 5th, 2008 @ 12:15:10 EST
1 Comment
Boston, MA -
Administration of bone marrow derived stem cells to patients post-infarct has demonstrated positive clinical results in double blind trials. Additionally, Osiris Therapeutics has reported
intravenous administration of allogeneic mesenchymal stem cells increases...
Friday February 29th, 2008 @ 15:52:20 EST
1 Comment
Shanghai, China -
It is known that various stem cell types, including
mesenchymal and
hematopoietic have the ability to home to injured tissue. Mechanisms of homing usually are associated with agents such as
stromal... Friday February 29th, 2008 @ 14:55:23 EST
1 Comment
Indianapolis, Indiana -
It is safe to say that the actual implimentation of stem cell therapy clinically is actually more being performed for purposes of immune modulation than actually growing of new tissues. For example, mesenchymal stem cells are most advanced clinically in the USA by the company Osiris, which are administering mesenchymal stem cells...
Sunday February 17th, 2008 @ 02:36:25 EST
1 Comment
Los Angeles, CA -
Tissue injury is known to cause mobilization of various types of stem cells. For example, after patients have a heart attack, CD34 stem cells, and other types of stem cells are known to
mobilize from the bone marrow and enter systemic circulation. Mobilization involves
Saturday February 16th, 2008 @ 19:51:40 EST